Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Updated: Reimbursement Questions Jeopardize Hillrom/Bardy Merger

Mar 04 2021

• By Reed Miller

Business deal failure concept as two businessmen on a road bridge that is breaking down and disconnecting — • Source: shutterstock.com

Related Content

Boston Scientific Bets Big On Monitoring; Buys Preventice For Up To $1.25Bn

Jan 22 2021

Thermo Fisher Scientific, Hillrom To Acquire Diagnostics Companies To Bolster Portfolios

Jan 21 2021

Cardiac Monitoring Companies Fight Medicare Reimbursement Cut By Novitas

Feb 06 2021

Related Companies

Hill-Rom Services Inc.

Bardy Diagnostics, Inc.

Additional Topics

Legal Issues M & A Reimbursement Digital Health Commercial Companies Diagnostics Cardiology Cardiovascular Medical Device

More from Legal & IP

More from Policy & Regulation

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window